Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Return on Capital Employed (2018 - 2020)

enVVeno Medical has reported Return on Capital Employed over the past 3 years, most recently at 2.1% for Q3 2020.

  • Quarterly results put Return on Capital Employed at 2.1% for Q3 2020, down 50.0% from a year ago — trailing twelve months through Sep 2020 was 2.1% (down 50.0% YoY), and the annual figure for FY2019 was 4.74%, up 102.0%.
  • Return on Capital Employed for Q3 2020 was 2.1% at enVVeno Medical, up from 24.08% in the prior quarter.
  • Over the last five years, Return on Capital Employed for NVNO hit a ceiling of 1.52% in Q2 2019 and a floor of 24.08% in Q2 2020.
  • Median Return on Capital Employed over the past 3 years was 2.73% (2019), compared with a mean of 5.84%.
  • Biggest five-year swings in Return on Capital Employed: fell -18bps in 2019 and later plummeted -2256bps in 2020.
  • enVVeno Medical's Return on Capital Employed stood at 2.64% in 2018, then fell by -7bps to 2.83% in 2019, then increased by 26bps to 2.1% in 2020.
  • The last three reported values for Return on Capital Employed were 2.1% (Q3 2020), 24.08% (Q2 2020), and 8.95% (Q1 2020) per Business Quant data.